Sfoglia per Autore
Clinical relevance of the assessment of deferasirox trough levels in thalassemia patients
2013-01-01 D. Massano; S. De Francia; F. Longo; A. Sandri; F. Piccione; E. Pirro; S. Allegra; A. D’Avolio; A. Piga.
Influence of single nucleotide polymorphisms on deferasirox Ctrough levels and effectiveness: study on beta-talassemia major affected patients
2014-01-01 De Francia S; Allegra S; D'Avolio A; Cusato J; Massano D; Pirro E; Racca S; Poli G
Identification of naïve HVC-4 patients who may be treated with pegylated-interferon and ribavirin according to IL28B polymorphisms.
2014-01-01 Boglione L;Cusato J;De Nicolò A;Cariti G;Allegra S;Ghisetti V; Di Perri G;D'Avolio A
Influence of single-nucleotide polymorphisms on deferasirox C-trough levels and effectiveness
2014-01-01 Cusato, J; Allegra, S; Massano, D; De Francia, S; Piga, A; D'Avolio, A.
Intracellular accumulation of atazanavir/ritonavir according to plasma concentrations and OATP1B1, ABCB1 and PXR genetic polymorphisms.
2014-01-01 D'Avolio A;Carcieri C;Cusato J;Simiele M;Calcagno A;Allegra S;Sciandra M;Trentini L;Di Perri G;Bonora S
Role of IL28-B polymorphisms in the treatment of chronic hepatitis B HBeAg-negative patients with peginterferon
2014-01-01 Lucio Boglione;Jessica Cusato;Sarah Allegra;Isabella Esposito;Francesca Patti;Giuseppe Cariti;Giovanni Di Perri;Antonio D’Avolio
VDR gene polymorphisms impact on anemia at 2 week of anti-HCV therapy: a possible mechanism for early RBV-induced anemia.
2015-01-01 Cusato, Jessica; Allegra, Sarah; Boglione, Lucio; De Nicolò, Amedeo; Cariti, Giuseppe; Di Perri, Giovanni; D’Avolio, Antonio
Role of pharmacogenetic in ribavirin outcome prediction and pharmacokinetics in an Italian cohort of HCV-1 and 4 patients
2015-01-01 Allegra, Sarah; Cusato, Jessica; DE NICOLO', Amedeo; Boglione, Lucio; Alberto, Gatto; Giuseppe, Cariti; DI PERRI, Giovanni; D'Avolio, Antonio
Evaluation of intracellular and plasma pharmacokinetics, pharmacogenetics and clinical features in HBV e antigen-negative patients treated with entecavir.
2015-01-01 Cusato, Jessica; De Nicolo’, Amedeo; Boglione, Lucio; Cardellino, Chiara Simona; Allegra, Sarah; Bonifacio, Gabriele; Cariti, Giuseppe; Giovanni Di Perri, ; D’Avolio, Antonio
UPLC-MS/MS method for the simultaneous quantification of anti-HBV nucleos(t)ides analogs: Entecavir, lamivudine, telbivudine and tenofovir in plasma of HBV infected patients
2015-01-01 DE NICOLO', Amedeo; Simiele, Marco; Pensi, Debora; Boglione, Lucio; Allegra, Sarah; DI PERRI, Giovanni; D'Avolio, Antonio
ABCB11 and ABCB1 gene polymorphisms impact on telaprevir pharmacokinetic at one month of therapy
2015-01-01 Cusato, Jessica; Allegra, Sarah; DE NICOLO', Amedeo; Boglione, Lucio; Fatiguso, Giovanna; Giuseppe, Cariti; Ciancio, Alessia; Smedile, Antonina; Strona, Silvia; Giulia, Troshina; Rizzetto, Mario; DI PERRI, Giovanni; D'Avolio, Antonio
Vitamin D pathway gene variants and HCV-2/3 therapy outcomes.
2015-01-01 Cusato, Jessica; Allegra, Sarah; Boglione, Lucio; DE NICOLO', Amedeo; Baietto, Lorena; Cariti, G; DI PERRI, Giovanni; D'Avolio, Antonio
Intracellular and Plasma Trough Concentration and Pharmacogenetics of Telaprevir
2015-01-01 Cusato, Jessica; Allegra, Sarah; DE NICOLO', Amedeo; Boglione, Lucio; Fatiguso, Giovanna; Mohamed Abdi, Adnan; Cariti, Giuseppe; DI PERRI, Giovanni; D'Avolio, Antonio
UPLC-MS/MS method with automated on-line SPE for the isomer-specific quantification of the first-generation anti-HCV protease inhibitors in peripheral blood mononuclear cells
2015-01-01 DE NICOLO', Amedeo; Abdi, Adnan Mohamed; Boglione, Lucio; Baietto, Lorena; Allegra, Sarah; DI PERRI, Giovanni; D'Avolio, Antonio
Intracellular accumulation of boceprevir according to plasma concentrations and pharmacogenetics
2015-01-01 Cusato, Jessica; Allegra, Sarah; DE NICOLO', Amedeo; Boglione, Lucio; Fatiguso, Giovanna; Adnan Mohamed Abdi, ; Giuseppe, Cariti; DI PERRI, Giovanni; D'Avolio, Antonio
Role of IL28B genotyping in patients with hepatitis C virus-associated mixed cryoglobulinemia and response to PEG-IFN and ribavirin treatment
2015-01-01 Boglione, Lucio; Cusato, Jessica; Allegra, Sarah; Cariti, Giuseppe; Di Perri, Giovanni; D'Avolio, Antonio
VDR gene polymorphisms impact on anemia at 2 weeks of anti-HCV therapy: a possible mechanism for early RBV-induced anemia.
2015-01-01 Cusato, Jessica; Allegra, Sarah; Boglione, Lucio; DE NICOLO', Amedeo; Cariti, G; DI PERRI, Giovanni; D'Avolio, Antonio
Influence of single-nucleotide polymorphisms on deferasirox C-trough levels and effectiveness.
2015-01-01 Cusato J;Allegra S;Massano D;De Francia S;Piga A;D'Avolio A
Effect of pharmacogenetic markers of vitamin D pathway on deferasirox pharmacokinetics in children
2016-01-01 Sarah Allegra, Jessica Cusato, Silvia De Francia, Arianna Arduino, Filomena Longo, Davide Massano, Antonio Piga, Antonio D'Avolio
Role of CYP24A1, VDR and GC gene polymorphisms on deferasirox pharmacokinetics and clinical outcomes
2016-01-01 Sarah Allegra, Silvia De Francia, Jessica Cusato, Arianna Arduino, Elisa Pirro, Davide Massano, Filomena Longo, Antonio Piga, Antonio D'Avolio.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Clinical relevance of the assessment of deferasirox trough levels in thalassemia patients | 2013 | D. Massano; S. De Francia; F. Longo; A. Sandri; F. Piccione; E. Pirro; S. Allegra; A. D’Avolio; A. Piga. | |
| Influence of single nucleotide polymorphisms on deferasirox Ctrough levels and effectiveness: study on beta-talassemia major affected patients | 2014 | De Francia S; Allegra S; D'Avolio A; Cusato J; Massano D; Pirro E; Racca S; Poli G | |
| Identification of naïve HVC-4 patients who may be treated with pegylated-interferon and ribavirin according to IL28B polymorphisms. | 2014 | Boglione L;Cusato J;De Nicolò A;Cariti G;Allegra S;Ghisetti V; Di Perri G;D'Avolio A | |
| Influence of single-nucleotide polymorphisms on deferasirox C-trough levels and effectiveness | 2014 | Cusato, J; Allegra, S; Massano, D; De Francia, S; Piga, A; D'Avolio, A. | |
| Intracellular accumulation of atazanavir/ritonavir according to plasma concentrations and OATP1B1, ABCB1 and PXR genetic polymorphisms. | 2014 | D'Avolio A;Carcieri C;Cusato J;Simiele M;Calcagno A;Allegra S;Sciandra M;Trentini L;Di Perri G;Bonora S | |
| Role of IL28-B polymorphisms in the treatment of chronic hepatitis B HBeAg-negative patients with peginterferon | 2014 | Lucio Boglione;Jessica Cusato;Sarah Allegra;Isabella Esposito;Francesca Patti;Giuseppe Cariti;Giovanni Di Perri;Antonio D’Avolio | |
| VDR gene polymorphisms impact on anemia at 2 week of anti-HCV therapy: a possible mechanism for early RBV-induced anemia. | 2015 | Cusato, Jessica; Allegra, Sarah; Boglione, Lucio; De Nicolò, Amedeo; Cariti, Giuseppe; Di Perri, Giovanni; D’Avolio, Antonio | |
| Role of pharmacogenetic in ribavirin outcome prediction and pharmacokinetics in an Italian cohort of HCV-1 and 4 patients | 2015 | Allegra, Sarah; Cusato, Jessica; DE NICOLO', Amedeo; Boglione, Lucio; Alberto, Gatto; Giuseppe, Cariti; DI PERRI, Giovanni; D'Avolio, Antonio | |
| Evaluation of intracellular and plasma pharmacokinetics, pharmacogenetics and clinical features in HBV e antigen-negative patients treated with entecavir. | 2015 | Cusato, Jessica; De Nicolo’, Amedeo; Boglione, Lucio; Cardellino, Chiara Simona; Allegra, Sarah; Bonifacio, Gabriele; Cariti, Giuseppe; Giovanni Di Perri, ; D’Avolio, Antonio | |
| UPLC-MS/MS method for the simultaneous quantification of anti-HBV nucleos(t)ides analogs: Entecavir, lamivudine, telbivudine and tenofovir in plasma of HBV infected patients | 2015 | DE NICOLO', Amedeo; Simiele, Marco; Pensi, Debora; Boglione, Lucio; Allegra, Sarah; DI PERRI, Giovanni; D'Avolio, Antonio | |
| ABCB11 and ABCB1 gene polymorphisms impact on telaprevir pharmacokinetic at one month of therapy | 2015 | Cusato, Jessica; Allegra, Sarah; DE NICOLO', Amedeo; Boglione, Lucio; Fatiguso, Giovanna; Giuseppe, Cariti; Ciancio, Alessia; Smedile, Antonina; Strona, Silvia; Giulia, Troshina; Rizzetto, Mario; DI PERRI, Giovanni; D'Avolio, Antonio | |
| Vitamin D pathway gene variants and HCV-2/3 therapy outcomes. | 2015 | Cusato, Jessica; Allegra, Sarah; Boglione, Lucio; DE NICOLO', Amedeo; Baietto, Lorena; Cariti, G; DI PERRI, Giovanni; D'Avolio, Antonio | |
| Intracellular and Plasma Trough Concentration and Pharmacogenetics of Telaprevir | 2015 | Cusato, Jessica; Allegra, Sarah; DE NICOLO', Amedeo; Boglione, Lucio; Fatiguso, Giovanna; Mohamed Abdi, Adnan; Cariti, Giuseppe; DI PERRI, Giovanni; D'Avolio, Antonio | |
| UPLC-MS/MS method with automated on-line SPE for the isomer-specific quantification of the first-generation anti-HCV protease inhibitors in peripheral blood mononuclear cells | 2015 | DE NICOLO', Amedeo; Abdi, Adnan Mohamed; Boglione, Lucio; Baietto, Lorena; Allegra, Sarah; DI PERRI, Giovanni; D'Avolio, Antonio | |
| Intracellular accumulation of boceprevir according to plasma concentrations and pharmacogenetics | 2015 | Cusato, Jessica; Allegra, Sarah; DE NICOLO', Amedeo; Boglione, Lucio; Fatiguso, Giovanna; Adnan Mohamed Abdi, ; Giuseppe, Cariti; DI PERRI, Giovanni; D'Avolio, Antonio | |
| Role of IL28B genotyping in patients with hepatitis C virus-associated mixed cryoglobulinemia and response to PEG-IFN and ribavirin treatment | 2015 | Boglione, Lucio; Cusato, Jessica; Allegra, Sarah; Cariti, Giuseppe; Di Perri, Giovanni; D'Avolio, Antonio | |
| VDR gene polymorphisms impact on anemia at 2 weeks of anti-HCV therapy: a possible mechanism for early RBV-induced anemia. | 2015 | Cusato, Jessica; Allegra, Sarah; Boglione, Lucio; DE NICOLO', Amedeo; Cariti, G; DI PERRI, Giovanni; D'Avolio, Antonio | |
| Influence of single-nucleotide polymorphisms on deferasirox C-trough levels and effectiveness. | 2015 | Cusato J;Allegra S;Massano D;De Francia S;Piga A;D'Avolio A | |
| Effect of pharmacogenetic markers of vitamin D pathway on deferasirox pharmacokinetics in children | 2016 | Sarah Allegra, Jessica Cusato, Silvia De Francia, Arianna Arduino, Filomena Longo, Davide Massano, Antonio Piga, Antonio D'Avolio | |
| Role of CYP24A1, VDR and GC gene polymorphisms on deferasirox pharmacokinetics and clinical outcomes | 2016 | Sarah Allegra, Silvia De Francia, Jessica Cusato, Arianna Arduino, Elisa Pirro, Davide Massano, Filomena Longo, Antonio Piga, Antonio D'Avolio. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile